In vivo, tumor cells can mediate adaptive resistance by upregulating PD-L1 in response to interferon-gamma (IFNγ) released by the cytotoxic T lymphocytes within the tumor bed (Garcia-Diaz et al., 2017). This evidence concerns the gene IFNG and neoplasm.